
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Quantum Biopharma is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its w... Quantum Biopharma is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly-owned subsidiary, Lucid Psycheceuticals Inc. ('Lucid'), Quantum Biopharma is focused on the research and development of its lead compound, Lucid-MS (formerly Lucid-21-302) ('Lucid-MS'). Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. Quantum Biopharma has also licensed unbuzzd(TM), a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of quickly relieving individuals from the effects of alcohol consumption for use in the consumer recreational sector, to Celly Nutrition Corp. ('Celly Nu'). Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.38 | -24.6428571429 | 5.6 | 7.2198 | 4.17 | 223683 | 5.25322578 | CS |
4 | -1.62 | -27.7397260274 | 5.84 | 18 | 4.17 | 7171792 | 9.1999905 | CS |
12 | 0.05 | 1.19904076739 | 4.17 | 18 | 2.7 | 2617446 | 8.99573198 | CS |
26 | 0.58 | 15.9340659341 | 3.64 | 18 | 2.7 | 1203490 | 8.84971131 | CS |
52 | -0.68 | -13.8775510204 | 4.9 | 18 | 2.7 | 1141813 | 8.63521645 | CS |
156 | -0.68 | -13.8775510204 | 4.9 | 18 | 2.7 | 1141813 | 8.63521645 | CS |
260 | -0.68 | -13.8775510204 | 4.9 | 18 | 2.7 | 1141813 | 8.63521645 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions